The Hong Kong-listed firm plans to boost Ethereum reserves and advance the ivd.xyz platform by acquiring up to HK$3 billion in crypto assets over three years, pending shareholder approval.
According to its official announcement, IVD Medical Holding Limited will seek shareholder approval to authorize up to HK$3 billion in cryptocurrency purchases, mainly Ethereum, over the next 36 months. The move aims to enhance ETH reserves and accelerate development of the ivd.xyz trading platform ecosystem. Transactions will be conducted via regulated venues such as HashKey Exchange and funded through idle cash or fundraising. The company will impose a 10% cap on any single purchase premium and has formed a dedicated risk control team to oversee implementation.